DPT-Hib vaccine explained

DPT-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis vaccine adsorbed with Hib conjugate vaccine, sometimes abbreviated to DPT-Hib.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.[1]

A branded formulation was marketed in the US as Tetramune by Lederle Praxis Biologicals (subsequently acquired by Wyeth).[2] Tetramune has since been discontinued.[3] [4]

Notes and References

  1. Web site: Diphtheria and Tetanus Toxoids and Pertussis Vaccine Adsorbed and Haemophilus B Conjugate Vaccine (Systemic). Drugs.com. 15 July 2018. 15 July 2018. https://web.archive.org/web/20180715210957/https://www.drugs.com/cons/DPT-Hib.html. dead.
  2. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children . MMWR. Morbidity and Mortality Weekly Report . 42 . 15 . 296–8 . April 1993 . 8479415 . 15 July 2018 . . Centers for Disease Control Prevention (CDC) .
  3. Web site: Selected Discontinued U.S. Vaccines. Centers for Disease Control and Prevention. 15 July 2018.
  4. Zarei AE, Almehdar HA, Redwan EM . Hib Vaccines: Past, Present, and Future Perspectives . Journal of Immunology Research . 2016 . 7203587 . 2016 . 26904695 . 4745871 . 10.1155/2016/7203587 . Table 1 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "DPT-Hib vaccine".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.